skip to main content

Breast Cancer

Physicians’ misunderstanding of genetic test results may hamper mastectomy decisions for breast cancer patients

Date Visible: 
Wednesday, April 12, 2017 - 16:00

A recent survey of over 2,000 women newly diagnosed with breast cancer found that half of those who undergo bilateral mastectomy after genetic testing don’t actually have mutations known to confer increased risk of additional cancers.

Looking beyond cancer cells to understand what makes breast cancer spread

Date Visible: 
Wednesday, February 15, 2017 - 11:15

A new study from researchers at the University of Michigan Comprehensive Cancer Center identifies a protein in that microenvironment that promotes the spread of breast cancer cells. It’s part of a well-known family of receptors for which promising inhibitors are being developed.

Doctor communication key to managing breast cancer patient risk worries

Date Visible: 
Monday, February 13, 2017 - 14:00

Nearly one-third of early stage breast cancer patients overestimate their risk of cancer recurrence — believing it to be more than double their actual risk. And that overestimation is affecting their quality of life, according to two recent studies. The good news? A more nuanced approach to doctor-patient communication may help improve patients’ understanding.

Medical assistant's cancer opens a door

Mimi Schork, a breast cancer survivor, used her diagnosis to move her toward a healthier lifestyle -- and led her to get involved in the American Cancer Society's Making Strides Against Breast Cancer.

Physicians fail to recommend genetic testing to many high-risk breast cancer patients

Date Visible: 
Tuesday, February 7, 2017 - 13:15

Physicians often fail to recommend genetic testing for breast cancer patients at high risk for mutations associated with ovarian and other cancers, according to a new study.

Half of breast cancer patients experience severe side effects

Date Visible: 
Tuesday, January 24, 2017 - 11:15

Nearly half of women treated for early stage breast cancer reported at least one side effect from their treatment that was severe or very severe, a new study finds.

Researchers find key genetic driver for rare type of triple-negative breast cancer

Date Visible: 
Thursday, January 5, 2017 - 10:00

By developing a new mouse model to study a poorly understood protein, researchers uncovered its link to metaplastic breast cancer, opening the door to better understanding of this challenging breast cancer subtype.

Pages